|
(MoneyNewsWire.Net, February 13, 2018 ) The Asia Pacific Rhinoconjunctivitis Market is worth USD xx million in 2016 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2021. The Asia Pacific Rhinoconjunctivitis market is developing at an exceptionally quick pace.
Rhinoconjunctivitis refers to a medical condition which is a combination of rhinitis and conjunctivitis and is one of the most common allergic reactions worldwide. It is an inflammatory disorder that affects nasal and conjunctival mucosa and is caused due to result of hypersensitive immune response. Sneezing, watery mucus, itchy nose, and nasal congestion, as well as conjunctivitis which include burning sensation, tears and redness of eyes are some of the common symptoms of Rhinoconjunctivitis. Poor sleep, irritability and fatigue are also some of the symptoms. According to an article published in Journal of Allergy and Therapy, allergic rhinitis is one of the most common reasons for hospital visits due to allergies.
Browse Market data tables and in-depth TOC of the Asia Pacific Rhinoconjunctivitis Market to 2021 @ https://www.marketdataforecast.com/market-reports/asia-pacific-rhinoconjunctivitis-market-5518/
Increasing awareness about Rhinoconjunctivitis is expected to be the major growth factor during the forecast period. Also improving medical infrastructure, increasing spending on healthcare and increasing number of pharmaceutical players involved in R&D in developing nations is expected to boost this industry.
The Asia Pacific Rhinoconjunctivitis market is segmented on the basis of Treatment and region. Based on treatment the market is segmented into Decongestants, Mast-Cell Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, and Intranasal Corticosteroids. In case of frequent symptoms intra-nasal corticosteroids are prescribed which include Avamys, Flonase, and Nasacort etc. If symptoms are occasional Claritin, Reactine (cetirizine), Aerius, Allegra (fexofenadine) are prescribed.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/asia-pacific-rhinoconjunctivitis-market-5518/request-sample
Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. Asia Pacific had the largest market and was also the fastest growing region. Factors like huge population, government initiatives and improving healthcare facilities in countries like China and India is expected to boost the industry in this region.
Johnson & Johnson Inc., Merck & Co., Inc., GlaxoSmithKline, Sanofi Adiga Life Sciences Inc. are the some key players in the Asia Pacific Rhinoconjunctivitismarket.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/asia-pacific-rhinoconjunctivitis-market-5518/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
